RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 123 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5 | +25.0% | 227 | 0.0% | 0.00% | – |
| Q2 2023 | $4 | 0.0% | 227 | 0.0% | 0.00% | – |
| Q1 2023 | $4 | -42.9% | 227 | 0.0% | 0.00% | – |
| Q4 2022 | $7 | -99.8% | 227 | +32.0% | 0.00% | – |
| Q3 2022 | $4,000 | +300.0% | 172 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 172 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 172 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 172 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 172 | +75.5% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 98 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 98 | +18.1% | 0.00% | – |
| Q4 2020 | $2,000 | -60.0% | 83 | -66.5% | 0.00% | – |
| Q3 2020 | $5,000 | +25.0% | 248 | 0.0% | 0.00% | – |
| Q2 2020 | $4,000 | 0.0% | 248 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | -33.3% | 248 | 0.0% | 0.00% | – |
| Q4 2019 | $6,000 | +20.0% | 248 | +13.2% | 0.00% | – |
| Q3 2019 | $5,000 | 0.0% | 219 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | -16.7% | 219 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | -25.0% | 219 | -27.0% | 0.00% | – |
| Q4 2018 | $8,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |